Identifying Critical Characteristics in a Rare Disease CRO Partner
A Question-First Approach to Operationalizing Rare Disease Studies
Rare disease clinical trials are intricate and challenging. Success is determined by a group of partner experts working collaboratively to innovate and adjust during projects.
This white paper is a guide to critical questions to ask when selecting a CRO to operationalize rare disease clinical studies. The answers that emerge are the optimal rare disease CRO characteristics: experienced, flexible, engaged, transparent, patient centric, and value-driven.
To learn more about Atlantic Research Group, visit our
website
.